# Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases

> **NCT06833489** · NA · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 50 (estimated)

## Conditions studied

- Rare Genetic Muscle Diseases
- Muscular Dystrophy, Duchenne
- Muscular Dystrophy, Becker
- Congenital Myopathy
- Pompe Disease (Infantile-Onset)

## Interventions

- **OTHER:** ARN extraction from muscle biopsies

## Key facts

- **NCT ID:** NCT06833489
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833489, "Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06833489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*